Switch to:
More From Other Websites
ARIAD to Present at the RBC Capital Markets Healthcare Conference Feb 10 2016
The Medicines Company Appoints Sarissa Capital Management Exec To Its Board Of Directors Feb 03 2016
ARIAD (ARIA) to Move AP32788 into Phase I/II Study in 2Q16 Feb 02 2016
ARIAD to Webcast Conference Call on Fourth Quarter and Year-End 2015 Financial Results Feb 02 2016
Ariad Announces FDA Has Given Clearance To Begin Clinical Development Trial Feb 01 2016
ARIAD Announces FDA Clearance to Begin Clinical Development of AP32788 Feb 01 2016
ARIAD Announces FDA Clearance to Begin Clinical Development of AP32788 Feb 01 2016
Equities Updates on Biotechnology -- Celldex Therapeutics, Amgen, Exelixis, and Ariad Pharma Jan 27 2016
Coverage initiated on Ariad Pharm by Barclays Jan 19 2016
ARIAD Pharmaceuticals (ARIA) Stock Gets ‘Underweight’ Rating at Barclays Jan 19 2016
Ariad preps for a sale, but new chairman says it may take time Jan 19 2016
ARIAD Reports Inducement Grant to New Chief Executive Officer Jan 15 2016
Ariad Pharmaceuticals (ARIA) Jumps: Stock Moves Up 7.4% Jan 13 2016
ARIAD PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement,... Jan 13 2016
Alex Denner on biotech selloff Jan 12 2016
ARIAD's Iclusig Regulatory Application Filed in Japan Jan 11 2016
ARIAD Announces Termination of Shareholder Rights Plan Jan 11 2016
ARIAD Announces Termination of Shareholder Rights Plan Jan 11 2016
ARIAD Announces Election of Alex Denner as Chairman of the Board of Directors Jan 10 2016
ARIAD Announces Election of Alex Denner as Chairman of the Board of Directors Jan 10 2016


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK